SRPT Duchenne Drug trial hits 5 year mark, page-35

True results, false conclusion. Scientists would say PBT2 is safe for most people tested. As for regulatory agencies, many more measurements will be reviewed and satisfiable animal toxicity results are just one of the prerequisites prior to human trials. That is understandable. Prana has informed us its PCH is due to dog results. FDA is always stringent, but options are still offered to Prana. So the question should be how Prana's management plans to clear those roadblocks. Why they don't resort to other animal models to provide more confirmative animal toxicity results? Why they are unable to satisfy FDA with sufficient clinical data or appropriate strategies for next clinical trials, eighteen months since PCH? We know they won't be able to provide more clinical data and present anything new due to PCH, so what are they doing now? Annual report will be due by the end of August. That is very important as future guidance. I do hope last run-up is based on some unknown progress not for somebody to unload their shares.